Clinical Application of PET Imaging Targeting CLDN18.2 in Malignant Tumors

Abroad (travel likely)Recruiting

Conditions

Gastric Cancer · Pancreatic Cancer · Cholangiocarcinoma Cancer · Esophageal Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Wuhan Union Hospital, China, Wuhan, Hubei, China
Contact: Study coordinator (Xiaoli Lan, PhD) · lxl730724@hotmail.com · +86-027-83692633

Study leads

Xiaoli Lan, PhD
Study Director
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

Diffuse Astrocytoma, IDH-Mutant · Glioblastoma, IDH-wildtype · Brain Metastases, Adult

Abroad (travel likely)RecruitingPHASE1, PHASE2

Beverly Hills, United States · Glendale, United States

A Study of MGC026 in Participants With Advanced Solid Tumors

Advanced Solid Tumor · Advanced Cancer · Metastatic Cancer

Abroad (travel likely)RecruitingPHASE1

Los Angeles, United States · Grand Rapids, United States

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

Brain Cancer · Breast Cancer · Bladder Cancer

Abroad (travel likely)Recruiting

Duarte, United States · Miami, United States

A Study of SI-B003, BL-B01D1+SI-B003 and BL-B01D1+PD-1 Monoclonal Antibody in Patients With Locally Advanced or Metastatic Esophageal Cancer, Gastric Cancer, Colorectal Cancer and Other Gastrointestinal Tumors

Esophageal Cancer · Gastric Cancer · Colorectal Cancer

Abroad (travel likely)RecruitingPHASE2

Beijing, China